Free Trial

Arbutus Biopharma (ABUS) News Today

$3.01
-0.05 (-1.63%)
(As of 06/18/2024 ET)
Arbutus Biopharma Co. (NASDAQ:ABUS) Short Interest Update
Arbutus Biopharma logo with Medical background
FourWorld Capital Management LLC Sells 251,056 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS)
FourWorld Capital Management LLC reduced its position in shares of Arbutus Biopharma Co. (NASDAQ:ABUS - Free Report) by 18.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,090,851 shares of the biopharmaceutical company's stock afte
Arbutus Biopharma logo with Medical background
Arbutus Biopharma (NASDAQ:ABUS) Trading Down 3%
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Down 3%
Arbutus Biopharma logo with Medical background
Arbutus Biopharma's (ABUS) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $5.00 target price on shares of Arbutus Biopharma in a research note on Thursday.
Arbutus Biopharma logo with Medical background
Arbutus Biopharma's (ABUS) Buy Rating Reiterated at Chardan Capital
Chardan Capital reiterated a "buy" rating and issued a $4.00 price objective on shares of Arbutus Biopharma in a research note on Wednesday.
Arbutus Biopharma logo with Medical background
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Up 5.7%
Arbutus Biopharma (NASDAQ:ABUS) Trading Up 5.7%
Arbutus Biopharma logo with Medical background
Arbutus Biopharma (NASDAQ:ABUS) Hits New 1-Year High at $3.44
Arbutus Biopharma (NASDAQ:ABUS) Sets New 52-Week High at $3.44
Arbutus Distributors Ltd. News Release
Arbutus Biopharma logo with Medical background
Arbutus Biopharma Co. (NASDAQ:ABUS) Sees Large Decline in Short Interest
Arbutus Biopharma Co. (NASDAQ:ABUS - Get Free Report) was the recipient of a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 5,340,000 shares, a drop of 8.1% from the April 30th total of 5,810,000 shares. Based on an average daily volume of 1,150,000 shares, the days-to-cover ratio is presently 4.6 days.
Arbutus Biopharma logo with Medical background
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Passes Above 200 Day Moving Average of $2.57
Arbutus Biopharma (NASDAQ:ABUS) Share Price Passes Above 200 Day Moving Average of $2.57
Arbutus Biopharma logo with Medical background
Arbutus Biopharma (NASDAQ:ABUS) Shares Down 4.7%
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Down 4.7%
Arbutus Biopharma logo with Medical background
Arbutus Biopharma (NASDAQ:ABUS) Reaches New 52-Week High at $3.29
Arbutus Biopharma (NASDAQ:ABUS) Reaches New 12-Month High at $3.29
Arbutus Biopharma logo with Medical background
Arbutus Biopharma (NASDAQ:ABUS) Trading Up 3.6%
Arbutus Biopharma (NASDAQ:ABUS) Trading Up 3.6%
Arbutus Biopharma Corp ABUS
Arbutus Biopharma's (ABUS) Buy Rating Reaffirmed at Chardan Capital
Chardan Capital reissued a "buy" rating and issued a $4.00 price target on shares of Arbutus Biopharma in a research note on Friday.
Arbutus: Q1 Earnings Snapshot
Arbutus Biopharma earnings: here's what to expect
Arbutus Biopharma Corp
Arbutus Biopharma (NASDAQ:ABUS) Sees Unusually-High Trading Volume
Arbutus Biopharma (NASDAQ:ABUS) Sees Large Volume Increase
Arbutus Biopharma (NASDAQ:ABUS) Earns "Market Outperform" Rating from JMP Securities
JMP Securities reiterated a "market outperform" rating and issued a $4.00 price objective on shares of Arbutus Biopharma in a research note on Thursday.
Arbutus Biopharma (NASDAQ:ABUS) Hits New 52-Week High at $3.25
Arbutus Biopharma (NASDAQ:ABUS) Reaches New 52-Week High at $3.25
Get Arbutus Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABUS and its competitors with MarketBeat's FREE daily newsletter.

Options expert shares his top option strategy for free (Ad)

A 35 year old man from central Florida has stumbled on one of the best strategies we’ve seen in a long time. For the last 30 months his “Friday to Monday” trading strategy has maintained a 71% win rate on more than 350 trades. That includes multiple big time winners like 82% from Adobe… 77% from Palo Alto… But also a barrage of smaller winners like 20% from AMC… Each of which were opened on a Friday afternoon and closed the very next Monday morning. As you’ll see in his brand new video, this strange strategy has given him the ability to capture big time market moves over the weekend.

Check it out, simply follow this link here.

ABUS Media Mentions By Week

ABUS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABUS
News Sentiment

1.61

0.73

Average
Medical
News Sentiment

ABUS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABUS Articles
This Week

3

2

ABUS Articles
Average Week

Get Arbutus Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABUS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ABUS) was last updated on 6/19/2024 by MarketBeat.com Staff

From Our Partners